T. Brabletz et al., NUCLEAR OVEREXPRESSION OF THE ONCOPROTEIN BETA-CATENIN IN COLORECTAL-CANCER IS LOCALIZED PREDOMINANTLY AT THE INVASION FRONT, Pathology research and practice, 194(10), 1998, pp. 701-704
Sixty to eighty percent of all colorectal cancers are characterized by
mutations in the APC tumor suppressor gene. Recently, it was shown th
at these mutations lead to a nuclear overexpression of beta-Catenin by
disruption of the wingless/WNT signal pathway. Since nuclear beta-Cat
enin functions as a transcriptional activator of hitherto unknown tumo
r genes, this form of beta-Catenin is now considered a major oncoprote
in in colorectal cancer. Using immunohistochemistry, we investigated t
he distribution of overexpressed beta-Catenin within individual colore
ctal carcinomas. In the majority of the tumors, we found no homogeneou
s staining, but a strong nuclear expression of beta-Catenin predominan
tly localized at the invasion front with strongest nuclear staining of
isolated, scattered tumor cells. In contrast, cells in the tumor cent
er often showed no nuclear staining, but retained a membranous express
ion of beta-Catenin, comparable to normal colon epithelium. It is, the
refore, likely that in addition to the overexpression of beta-Catenin
caused by defects in the APC locus, regulatory events in the tumor its
elf lead to a different distribution of this oncoprotein. Possibly, su
rrounding tissue at the invasion front can give signals to the tumor c
ells, leading to a nuclear translocation of beta-Catenin, where it may
play a direct role in tumor invasion processes.